Metformin upregulates the core clock gene PER2 in GBM cell lines, regulates the SIRT2/G6PD signaling pathway in a PER2-dependent manner, and has synergistic effects on the radiotherapy sensitivity of GBM cell lines. The gene discussed is G6PD; the disease is glioblastoma.